viral transcription
Showing 1 - 25 of 4,217
HIV-1-infection, Methamphetamine-dependence Trial in San Francisco (Oral Methamphetamine, Placebo oral capsule)
Recruiting
- HIV-1-infection
- Methamphetamine-dependence
- Oral Methamphetamine
- Placebo oral capsule
-
San Francisco, CaliforniaSan Francisco General Hospital
Mar 22, 2022
HIV Trial in Barcelona (Control group , Experimental group 1 lauric acid, Experimental group 2 lauric acid)
Recruiting
- HIV Infections
- Control group placebo
- +2 more
-
Barcelona, SpainHospital Universitario Vall d´Hebron
Jan 13, 2023
Aicardi-Goutières Syndrome Trial in Edinburgh (Abacavir (ABC), Lamivudine (3TC), Abacavir (ABC)+Lamivudine (3TC)+Zidovudine
Recruiting
- Aicardi-Goutières Syndrome
- Abacavir (ABC)
- +2 more
-
Edinburgh, United KingdomYanick Crow
Aug 26, 2022
Influenza Trial in Baltimore, Durham (Influenza RG-A/Texas/71/2017 (H3N2) Challenge, Placebo)
Recruiting
- Influenza
- Influenza RG-A/Texas/71/2017 (H3N2) Challenge
- Placebo
-
Baltimore, Maryland
- +1 more
Aug 4, 2022
HIV Infection Trial in Cleveland (Recombinant Interleukin-2)
Terminated
- HIV Infection
- Recombinant Interleukin-2
-
Cleveland, OhioAIDS Clinical Trials Unit
Sep 1, 2022
Viral Dynamics of Omicron in Children
Completed
- SARS-CoV2 Infection, COVID-19
- Daily SARS-CoV-2 PCR Testing for 10 days
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Nov 25, 2022
COVID-19 in Baselland: Validation of Simple and Accurate Tests
Recruiting
- Coronavirus Infectious Disease 2019 (COVID-19)
- Saliva based assay: crude RNA extraction
- +3 more
-
Liestal, SwitzerlandCantonal Office of Public Health, Economics and Health Directora
Dec 9, 2022
Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts
Not yet recruiting
- Warts
- Detection of expression of SOCS3 gene
- +2 more
- (no location specified)
Mar 12, 2023
SARS-CoV-2 Infection, COVID-19 Trial in Derby (Remdesivir)
Not yet recruiting
- SARS-CoV-2 Infection
- COVID-19
-
Derby, United KingdomUniversity of Derby
Jun 21, 2023
HIV-1-infection, Subtype b Trial (Decitabine cycle 1, Romidepsin cycle 1, Decitabine cycle 2)
Recruiting
- HIV-1-infection, Subtype b
- Decitabine cycle 1
- +7 more
-
Bruxelles, Belgium
- +2 more
Jan 30, 2023
Respiratory Syncytial Virus Trial in London (Molnupiravir, Placebo, RSV A Memphis 37b)
Recruiting
- Respiratory Syncytial Virus
- Molnupiravir
- +2 more
-
London, London, City Of, United KingdomhVIVO Services ( Site 0001)
Feb 2, 2023
ImmuneSense™ COVID-19 Cross-Reactivity Study
Suspended
- Coronavirus Disease
- SARS-CoV-2 Infection
-
Seattle, WashingtonAdaptive Biotechnologies
Aug 3, 2022
Virus Infection, RNA Trial in Los Angeles (GenX intergenerational mentoring program)
Not yet recruiting
- Virus Infection, RNA
- GenX intergenerational mentoring program
-
Los Angeles, CaliforniaUCLA School of Medicine
Sep 6, 2022
Human Papillomavirus-Related Malignant Tumor Trial in Wuhan (T512)
Recruiting
- Human Papillomavirus-Related Malignant Neoplasm
- T512
-
Wuhan, Hubei, ChinaTongji Hospital
Dec 29, 2021
SARS-CoV-2, COVID-19, Mouthwashes Trial in Jeddah (Distilled Water, 1% Povidone Iodine (PVP-I), 1.5% Hydrogen Peroxide (H2O2))
Completed
- SARS-CoV-2
- +7 more
- Distilled Water
- +5 more
-
Jeddah, Saudi ArabiaAlhamra TETAMMAN clinic (PHC)
Jul 18, 2022
SARS-CoV-2 Infection Trial in Mexico City (Recombinant NDV Vectored Vaccine for SARS-CoV-2)
Completed
- SARS-CoV-2 Infection
- Recombinant NDV Vectored Vaccine for SARS-CoV-2
-
Mexico City, Ciudad De Mexico, MexicoHospital Medica Sur
Dec 8, 2022
Advanced Malignant Solid Tumor, Anal Carcinoma, HIV Infection Trial in Australia, United States (Ipilimumab, Nivolumab)
Recruiting
- Advanced Malignant Solid Neoplasm
- +8 more
- Ipilimumab
- Nivolumab
-
La Jolla, California
- +34 more
Nov 29, 2022
Covid19 Trial in Sao Paulo (CPC+ZN, CPC, Negative Control)
Completed
- Covid19
- CPC+ZN
- +2 more
-
Sao Paulo, BrazilHospital israelita Albert Einstein
Feb 24, 2022
Respiratory Viral Infection Trial (Nasal Spray)
Not yet recruiting
- Respiratory Viral Infection
- Nasal Spray
- (no location specified)
Nov 19, 2022
Respiratory Syncytial Viruses Trial in London (MK-1654, Placebo, RSV-A Memphis 37b)
Completed
- Respiratory Syncytial Viruses
- Clesrovimab
- +2 more
-
London, United KingdomHVIVO Services Ltd ( Site 0001)
Aug 29, 2022
COVID-19 Trial
Not yet recruiting
- COVID-19
- (no location specified)
Jan 12, 2022
Dravet Syndrome Trial in Melbourne (ETX101)
Not yet recruiting
- Dravet Syndrome
-
Melbourne, AustraliaThe Royal Children's Hospital
Oct 30, 2023
Influenza, Human Trial (Fluzone Quadrivalent, Flublok Quadrivalent)
Not yet recruiting
- Influenza, Human
- Fluzone Quadrivalent
- Flublok Quadrivalent
- (no location specified)
Aug 22, 2022